{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:13:32Z","timestamp":1789910012638,"version":"4.0.1"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cystic Fibrosis Trust (GB)","award":["VIA011"],"award-info":[{"award-number":["VIA011"]}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics","doi-asserted-by":"publisher","award":["HARRIS14XX0"],"award-info":[{"award-number":["HARRIS14XX0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184009","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T13:26:34Z","timestamp":1504272394000},"page":"e0184009","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":84,"title":["Cas9\/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA"],"prefix":"10.1371","volume":"12","author":[{"given":"David J.","family":"Sanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Hollywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina F.","family":"Scallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2319-0949","authenticated-orcid":true,"given":"Patrick T.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"GR Cutting","year":"2015","journal-title":"Nat Rev Genet"},{"issue":"4922","key":"ref2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"JM Rommens","year":"1989","journal-title":"Science"},{"issue":"4922","key":"ref3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"JR Riordan","year":"1989","journal-title":"Science"},{"issue":"4922","key":"ref4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"B Kerem","year":"1989","journal-title":"Science"},{"issue":"Suppl 1","key":"ref5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prrv.2013.01.006","article-title":"CFTR2: How will it help care?","volume":"14","author":"C Castellani","year":"2013","journal-title":"Paediatr Respir Rev"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","article-title":"Molecular mechanisms of <italic>CFTR<\/italic> chloride channel dysfunction in cystic fibrosis","volume":"73","author":"MJ Welsh","year":"1993","journal-title":"Cell"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.E14-04-0935","article-title":"From <italic>CFTR<\/italic> biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"G Veit","year":"2016","journal-title":"Mol Biol Cell"},{"issue":"18","key":"ref8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"BW Ramsey","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcf.2011.12.005","article-title":"Ivacaftor potentiation of multiple CFTR channels with gating mutations","volume":"11","author":"H Yu","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(15)00201-5","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial","volume":"3","author":"RB Moss","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"CE Wainwright","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcf.2016.09.005","article-title":"Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation","volume":"16","author":"V Mutyam","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral <italic>CFTR<\/italic> gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"EW Alton","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"S44","key":"ref14","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/ppul.23543","article-title":"Genetic medicines for CF: Hype versus reality","volume":"51","author":"EW Alton","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00439-016-1693-3","article-title":"Impact of gene editing on the study of cystic fibrosis","volume":"135","author":"PT Harrison","year":"2016","journal-title":"Hum Genet"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"e0161072","DOI":"10.1371\/journal.pone.0161072","article-title":"Targeted Integration of a Super-Exon into the <italic>CFTR<\/italic> Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model","volume":"11","author":"C Bednarski","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/biores.2012.0218","article-title":"Correction of the \u0394F508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Gene by Zinc-Finger Nuclease Homology-Directed Repair","volume":"1","author":"CM Lee","year":"2012","journal-title":"Biores Open Access"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"32230","DOI":"10.1038\/srep32230","article-title":"Analysis of gene repair tracts from Cas9\/gRNA double-stranded breaks in the human <italic>CFTR<\/italic> gene","volume":"6","author":"JA Hollywood","year":"2016","journal-title":"Sci Rep"},{"issue":"20","key":"ref19","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1093\/nar\/gkt772","article-title":"Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease","volume":"41","author":"W Fujii","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0022-2836(92)90320-J","article-title":"Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites","volume":"228","author":"RM Stephens","year":"1992","journal-title":"J Mol Biol"},{"issue":"3","key":"ref21","first-page":"623","article-title":"A novel donor splice site in intron 11 of the <italic>CFTR<\/italic> gene, created by mutation 1811+1.6kbA\u2014&gt;G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype","volume":"56","author":"M Chill\u00f3n","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.0.CO;2-T","article-title":"Cystic fibrosis patients with the 3272-26A\u2014&gt;G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane","volume":"14","author":"S Beck","year":"1999","journal-title":"Hum Mutat"},{"issue":"15","key":"ref23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199410133311503","article-title":"A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations","volume":"331","author":"WE Highsmith","year":"1994","journal-title":"N Engl J Med"},{"issue":"8970","key":"ref24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0140-6736(95)92165-6","article-title":"3849+10 kb C\u2014&gt;T mutation and disease severity in cystic fibrosis","volume":"346","author":"RC Stern","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/geno.1998.5517","article-title":"The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C\u2014&gt;T mutation","volume":"53","author":"O Chiba-Falek","year":"1998","journal-title":"Genomics"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/9.12.1771","article-title":"Cellular and viral splicing factors can modify the splicing pattern of <italic>CFTR<\/italic> transcripts carrying splicing mutations","volume":"9","author":"M Nissim-Rafinia","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"FA Ran","year":"2013","journal-title":"Nat Protoc"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1165\/ajrcmb\/8.5.522","article-title":"An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation","volume":"8","author":"K Kunzelmann","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/MCB.7.1.379","article-title":"Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system","volume":"7","author":"RB DuBridge","year":"1987","journal-title":"Mol Cell Biol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1158\/1078-0432.CCR-09-2564","article-title":"A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast\/ovarian cancer patients","volume":"16","author":"DJ Sanz","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/humu.22624","article-title":"Experimental assessment of splicing variants using expression minigenes and comparison with in silico predictions","volume":"35","author":"N Sharma","year":"2014","journal-title":"Hum Mutat"},{"issue":"1","key":"ref32","first-page":"169","article-title":"Heteroduplex formation in polymerase chain reaction","volume":"47","author":"F Anglani","year":"1990","journal-title":"Am J Hum Genet"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1165\/rcmb.2001-0004OC","article-title":"Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis","volume":"27","author":"AS Ramalho","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/viro.1993.1234","article-title":"Two adenovirus proteins with redundant activities in virus growth facilitates tripartite leader mRNA accumulation","volume":"194","author":"K Ohman","year":"1993","journal-title":"Virology"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"FL Graham","year":"1977","journal-title":"J Gen Virol"},{"issue":"10","key":"ref36","first-page":"859","article-title":"Gene targeting of <italic>CFTR<\/italic> DNA in CF epithelial cells","volume":"3","author":"K Kunzelmann","year":"1996","journal-title":"Gene Ther"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/hmg\/7.12.1913","article-title":"Targeted replacement of normal and mutant <italic>CFTR<\/italic> sequences in human airway epithelial cells using DNA fragments","volume":"7","author":"KK Goncz","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.gt.3301476","article-title":"Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of <italic>CFTR<\/italic> sequences by SFHR","volume":"8","author":"KK Goncz","year":"2001","journal-title":"Gene Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/ncomms7952","article-title":"Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium","volume":"6","author":"NA McNeer","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0992-21","article-title":"Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis","volume":"2","author":"LG Johnson","year":"1992","journal-title":"Nat Genet"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"e1000155","DOI":"10.1371\/journal.pbio.1000155","article-title":"CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium","volume":"7","author":"L Zhang","year":"2009","journal-title":"PLoS Biol"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"S Kim","year":"2014","journal-title":"Genome Res"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.171264.113","article-title":"Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA","volume":"24","author":"S Ramakrishna","year":"2014","journal-title":"Genome Res"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/gt.2016.27","article-title":"Lentivirus pre-packed with Cas9 protein for safer gene editing","volume":"23","author":"JG Choi","year":"2016","journal-title":"Gene Ther"},{"issue":"374","key":"ref45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj2013","article-title":"Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells","volume":"9","author":"W Qasim","year":"2017","journal-title":"Sci Transl Med"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In Vivo CRISPR\/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa","volume":"24","author":"B Bakondi","year":"2016","journal-title":"Mol Ther"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","article-title":"A multifunctional AAV-CRISPR-Cas9 and its host response","volume":"13","author":"WL Chew","year":"2016","journal-title":"Nat Methods"},{"issue":"14","key":"ref48","doi-asserted-by":"crossref","first-page":"e88728","DOI":"10.1172\/jci.insight.88728","article-title":"<italic>CFTR<\/italic> gene transfer with AAV improves early cystic fibrosis pig phenotypes","volume":"1","author":"B Steines","year":"2016","journal-title":"JCI Insight"},{"issue":"14","key":"ref49","doi-asserted-by":"crossref","first-page":"e88730","DOI":"10.1172\/jci.insight.88730","article-title":"Lentiviral-mediated phenotypic correction of cystic fibrosis pigs","volume":"1","author":"AL Cooney","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","article-title":"Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis","volume":"72","author":"EW Alton","year":"2017","journal-title":"Thorax"},{"issue":"10","key":"ref51","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"P Tebas","year":"2014","journal-title":"N Engl J Med"},{"issue":"51","key":"ref52","doi-asserted-by":"crossref","first-page":"36193","DOI":"10.1074\/jbc.274.51.36193","article-title":"Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (<italic>CFTR<\/italic>) gene by antisense oligonucleotides","volume":"274","author":"KJ Friedman","year":"1999","journal-title":"J Biol Chem"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.embor.7400273","article-title":"Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation","volume":"5","author":"M Nissim-Rafinia","year":"2004","journal-title":"EMBO Rep"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1165\/rcmb.2012-0371OC","article-title":"Fine characterization of the recurrent c.1584+18672A&gt;G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene","volume":"48","author":"L Costantino","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ajhg.2017.04.001","article-title":"Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites","volume":"100","author":"M Lee","year":"2017","journal-title":"Am J Hum Genet"},{"key":"ref56","article-title":"Deep intronic mutations and human disease","author":"R Vaz-Drago","year":"2017","journal-title":"Hum Genet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:57:22Z","timestamp":1540216642000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184009"}},"subtitle":[],"editor":[{"given":"Emanuele","family":"Buratti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184009","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}